Pharmacology of adapalene

British Journal of Dermatology, Supplement

Volumn 139, Issue 52, 1998, Pages 3-7

  Michel, S ^a   Jomard, A ^a   Demarchez M ^a  

^a GaMerma R and 0 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; CELL NUCLEUS RECEPTOR; RETINOIC ACID; RETINOID DERIVATIVE;

ACNE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIFFERENTIATION; CELL DIVISION; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; HELA CELLS; HUMANS; KERATINOCYTES; NAPHTHALENES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SKIN; TRETINOIN;

EID: 0031697368     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB ] 1996; 10: 940-54.
2. Shapiro SS. Retinoids and epithelial differentiation. In: Retinoids and cell differentiation (Sherman MI, ed.). Boca Raton: CRC Press, Inc. 1986; 29-59.
3. Asselineau D, Bernard BA, Bailly C, Darmon M. Retinoic acid improves epidermal morphogenesis. Dev Biol 1989; 133: 322-35.
4. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 624-9.
5. De Thé H, Marchio A, Tiollais P, Dejean A. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 1989: 330: 667-70.
6. Krust A, Kastner Ph, Petkovich M et al. A third human retinoic acid receptor, hRAR-y. Proc Natl Acad Sci 1989; 86: 5310-4.
7. Mangelsdorf DJ, Borgmeyer U, Ileyman RA et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329-44.
8. Levin AA, Sturzenbecker LJ, Kazmcr S et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992: 355: 359-61.
9. Zhang X-K, Hoffmann B, Tran PBV et al Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441-6.
10. Umesono K, Murakami KK, Thompson CC. Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin Dj receptors. Cell 1991: 65: 1255-66.
11. Zhang XK, Lehmann J, Hoffmann B et al Homodimer formation of retinoid X receptor induced by 9-ris retinoic acid. Nature 1992b; 358: 587-91.
12. Schaefer II, Reichert U. Retinoids and their perspectives in dermatology. Nouv Dermatol 1990; 9: 3-6.
13. Martin B, Bernardon JM, Cavey MT et al Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmacol 1992; 5: 57-5.
14. Strickland S, Madhdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393-03.
15. Bailly J, Delescluse C, Bernardon JM et al Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: amplitude of plasminogen activator production does not depend on retinoid potency or affinity for F9 nuclear retinoic acid receptors. Skin Pharmacol 1990; 3: 256-67.
16. Reichert U, Michel S, Schmidt R. The comified envelope: a key structure of terminally differentiating keratinocytes. In: Molecular Biology of the Skin: The Keratinocyte (Blumenberg M, Darmon M, eds). New York: Academic Press, 1993; 107-50.
17. Michel S. Courseaux A, Miquel C et al. Determination of retinoid activity by an enzyme-linked immunosorbent assay. Anal Biochem 1991; 192: 232-6.
18. Asselineau D, Bernard BA, Bailly C et al Human epidermis reconstructed by culture: is it 'normal'? J Invest Dermatol 1986; 86: 181-6.
19. Bouclier M, Chatelus A, Ferracin J et al. Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol 1991; 4: 65-3.
20. Bernerd F, Ortonne JP, Bouclier M et al. The Rhino mouse model: the effects of topically applied all-frans retinoic acid and CD 271 on the fine structure of the epidermis and utricule wall of pseudocomedones. Arch Dermatol Res 1991: 283: 100-7.
21. Hensby C, Cavey D, Bouclier M et al The in vivo and in vitro antiinflammatory activity of CD 271: a new retinoid-like modulator of cell differentiation. Agents Actions 1990; 29: 1-2.
22. Pfahl M. Nuclear Receptor/AP-1 Interaction. Endocrine Rev 1993; 14: 651-8.
23. Angel P, Baumann I, Stein B et al. 12-0-tetradecanoyl-phorbol13-acetate (TPA) induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5' flanking region. Mol Cell Biol 1987; 7: 2256-66.
24. Lotan R, Kramer RH, Neumann G et al Retinoic acid-induced modifications in the growth and cell surface components of a human carcinoma (Heia) cell line. Exp Cell Res 1980; 130: 401-14.
25. Bouclier M, Dionisus V, Shroot B et al A rapid and simple test system for the evaluation of the inhibitory activity of topical retinoids on cellotape stopping-induced ODC activity in the hairless rat. Dcrmatologica 1984; 169: 242-3.
26. Cunlifie WJ, Caputo R, Dreno B et al Efficacy and safety comparison of adapalene (CD271) gel and tretinoin gel in the topical treatment of acne vulgaris. A European multicentre trial. J Dermatol Treatment 1997: 8: 173-8.